Johnson County Republicans differ in their reactions to Capitol attack, end of Trump presidency GOP leaders in Johnson County say the party s brand is resilient and its values will survive the Trump era. But other party members say the recent attack on the U.S. Capitol by a mob of far-right extremists was the final break. File photo.
In the aftermath of the attack on the U.S. Capitol nearly two weeks ago carried out by a mob of pro-Trump extremists, Republicans in Johnson County have been reacting in a variety of ways.
Some local party leaders have urged healing while also expressing support for both Kansas Sen. Robert Marshall, a first-term Republican who voted against certifying some states’ electors, and Sen. Jerry Moran, who voted the opposite way. But other party members say the attack along with Joe Biden’s victory in November, including taking Johnson County should be a warning to the local GOP.
How the availability of first COVID-19 vaccines could impact the development of new vaccines
18 vaccines in final stages of testing
Frank McGeorge, MD, Local 4 s Good Health Medical Expert
Tags:
DETROIT – What does the availability of the Pfizer and ModernaCOVID-19 vaccines mean for all the other trials?
There are 63 vaccines in human clinical trials and 18 of them are in the final stages of testing. Another 85 are being tested in animals.
The first vaccines are not necessarily going to turn out to be the best vaccines. Other vaccines still in development could work better for certain groups, like children or have qualities that make them more practical. For example, Johnson and Johnson’s vaccine only requires one dose.
Vaccine trial dropouts pose dilemma for manufacturers16/12/2020|2min
Vaccine trial dropouts are posing a dilemma for companies creating coronavirus vaccines.
INOVIO vaccine trial participant Brandon Kenig has said he would like to receive an approved vaccine when one is released and by doing so, will need to drop out of the INOVIO trials.
Mr Kenig has been involved in the INOVIO vaccine phase one trials since the spring; the trial includes 48 people who received vaccines.
Principle Investigator Dr John Ervin said participant dropouts are a dilemma he’s anticipated since the trials began.
“These studies are voluntary, and I think we have to have what’s best for the individual as our main interest,’ Mr Ervin said.
Experts say approved vaccines could raise drop-out concerns for later trials
Experts are concerned approved vaccines could make it harder to find trial participants for later rounds. They say trial drop-out rates could increase, too.
and last updated 2020-12-14 19:40:27-05
KANSAS CITY, Mo. â While Pfizer s Covid-19 vaccine is approved for public use, doctors say it s important to keep in mind multiple vaccines are needed to help end the pandemic as soon as possible.
Several trials are still underway for other COVID-19 vaccines. Those that begin later than others could face problems with having enough participants or participants dropping out to receive an approved vaccine when it s available to them.